Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:52:30.348Z.
Calculation as of: 2026-10-06T18:52:30.348Z.
Quote observation: 2026-10-06T18:50:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4ee4545eb4fe5103374f291c717036760539f0ddea1c9b76c24efb1a2679ece0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Odyssey Therapeutics, Inc.
Market Cap
$882.10M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$880.85M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$882.99M
Operating Cash Flow Yield
N/A
TTM Avg
8.30%
3Y Avg
22.27%
5Y Avg
22.27%
Market Cap
$863.59M
Operating Cash Flow Yield
9.19%
TTM Avg
10.90%
3Y Avg
9.30%
5Y Avg
6.80%
Market Cap
$898.60M
Operating Cash Flow Yield
10.78%
TTM Avg
11.28%
3Y Avg
6.74%
5Y Avg
6.11%
Market Cap
$857.96M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$856.66M
Operating Cash Flow Yield
0.29%
TTM Avg
0.28%
3Y Avg
0.28%
5Y Avg
0.28%
Market Cap
$912.77M
Operating Cash Flow Yield
7.86%
TTM Avg
8.82%
3Y Avg
7.69%
5Y Avg
7.20%
Market Cap
$849.50M
Operating Cash Flow Yield
N/A
TTM Avg
1.45%
3Y Avg
1.45%
5Y Avg
1.45%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Odyssey Therapeutics, Inc. (ODTX) | $882.10M | N/A | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $880.85M | N/A | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $882.99M | N/A | 8.30% | 22.27% | 22.27% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $863.59M | 9.19% | 10.90% | 9.30% | 6.80% |
| Bioventus Inc. (BVS)vs › | $898.60M | 10.78% | 11.28% | 6.74% | 6.11% |
| SL Science Holding Ltd (SLBT)vs › | $857.96M | N/A | N/A | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $856.66M | 0.29% | 0.28% | 0.28% | 0.28% |
| HealthStream, Inc. (HSTM)vs › | $912.77M | 7.86% | 8.82% | 7.69% | 7.20% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $849.50M | N/A | 1.45% | 1.45% | 1.45% |
| QuidelOrtho Corporation (QDEL)vs › | $846.74M | N/A | 5.54% | 5.51% | 9.92% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
